Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review (Q36396145)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

1 reference

Europe PubMed Central

Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

0 references

type 2 diabetes

0 references

0 references

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

Eleuterio Ferrannini

2

object named as

Ferrannini E

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

author name string

Natali A

1

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

publication date

14 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

434-441

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Metformin increases insulin sensitivity and basal glucose clearance in Type 2 (non-insulin dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-006-0141-7

21 January 2018

The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of metformin and rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed type 2 diabetes: a randomized controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic and drug distribution studies do not support direct inhibitory effects of metformin on intestinal glucose absorption

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of pioglitazone compared with metformin on glycemic control and indicators of insulin sensitivity in recently diagnosed patients with type 2 diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of troglitazone in young first-degree relatives of patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Re-evaluation of a biguanide, metformin: mechanism of action and tolerability

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibitory effect of metformin on intestinal glucose absorption in the perfused rat intestine

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin resistance: From predisposing factor to therapeutic target in type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin Therapy in Obese, Non-insulin-dependent Diabetes Induces Improvements in Insulin Action and Secretion that Are Maintained for Two Weeks After Insulin Withdrawal

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Troglitazone treatment increases protein kinase B phosphorylation in skeletal muscle of normoglycemic subjects at risk for the development of type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin: new understandings, new uses

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of prolonged glucose infusion on insulin secretion, clearance, and action in normal subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16477438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-006-0141-7

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36396145&oldid=2198830125"